Multiple Sclerosis Therapeutics Market Research, Growth Opportunities
The global multiple sclerosis therapeutics market was valued at US$ 19.6 billion in 2016 and is expected to witness a robust CAGR of 2.5% over the forecast period (2017 – 2025).
The global multiple sclerosis therapeutics market was valued at US$ 19.6 billion in 2016 and is expected to witness a robust CAGR of 2.5% over the forecast period (2017 – 2025).
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Multiple</strong> <strong>Sclerosis</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND<br />
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION<br />
<strong>Multiple</strong> <strong>Sclerosis</strong> <strong>Therapeutics</strong> <strong>Market</strong> – Overview<br />
The types of MS include relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and secondary<br />
progressive MS (SPMS). RPMS is the most common type characterized by defined attacks with increasing<br />
neurological symptoms, PPMS is the rare form characterized by gradual progression of disease, whereas<br />
SPMS is commonly identified in people living with relapsed-remitting MS. The most common symptoms<br />
of the disease include partial or complete vision loss, prolonged vision loss, lack of coordination, and<br />
slurred speech.<br />
A combination of genetic and environmental factors is responsible for the occurrence of the condition.<br />
According to a study by International Progressive Alliance, 2013, MS is two to three times more common<br />
in women than in men, suggesting that hormones play a significant role in determining susceptibility to the<br />
disease.<br />
The global multiple sclerosis therapeutics market was valued at US$ 19.6 billion in 2016 and is expected to<br />
witness a robust CAGR of 2.5% over the forecast period (2017 – 2025).
REPORT DESCRIPTION<br />
<strong>Multiple</strong> <strong>Sclerosis</strong> <strong>Therapeutics</strong> <strong>Market</strong> – Dynamics<br />
Fail-safe packaging of pharmaceutical products is important so that medications and therapeutic products<br />
reach patients safely. Therefore, pharmaceutical companies focus on investments to purchase equipment,<br />
which can offer advanced packaging solutions for medications. For instance, in June 2017, Bosch<br />
Packaging Technology launched ALF 5000 —a pharmaceutical filing and closing machine. ALF 5000<br />
offers a wide range of filling systems as the platform can be equipped with all established filling systems<br />
such as peristaltic pump or time-pressure-filling system and optionally comes with four, six, eight, 10 or 12<br />
filling points.<br />
Furthermore, stringent regulations that mandate pharmaceutical companies to adhere to certain standards<br />
for packaging of drugs is also positively impacting the pharmaceutical packaging equipment market<br />
growth. This creates growing opportunities for pharmaceutical manufacturers to outsource its<br />
pharmaceutical packaging capabilities, thereby shifting regulatory burden on these organizations.<br />
Get PDF Brochure @<br />
https://www.coherentmarketinsights.com/insight/request-pdf/1310
REPORT DESCRIPTION<br />
<strong>Multiple</strong> <strong>Sclerosis</strong> <strong>Therapeutics</strong> <strong>Market</strong> – Key Players<br />
• Novartis AG<br />
• Teva Pharmaceutical Industries Ltd.<br />
• Sanofi S.A.<br />
• Bayer AG<br />
• Pfizer, Inc.<br />
• Biogen Idec<br />
• Merck & Co., Inc.<br />
• AbbVie<br />
Read More @<br />
https://www.coherentmarketinsights.com/market-insight/multiple-sclerosis-therapeutics-market-1310
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> Insights is a global market intelligence and consulting organization focused on assisting its<br />
plethora of clients achieve transformational growth by helping them make critical business decisions. We are<br />
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players<br />
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help<br />
businesses around the globe deliver practical and lasting results through various recommendations about<br />
operational improvements, technologies, emerging market trends and new working methods. We offer both<br />
customized and syndicated market research reports that help our clients create visionary growth plans to<br />
provide traction to their business. We meticulously study emerging trends across various industries at both the<br />
global and regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH<br />
MARKET INTELLIGENCE SERVICES<br />
CONSULT STUDIES<br />
COUNTRY SPECIFIC STUDIES
ABOUT CMI<br />
SECTOR<br />
COVERAGE<br />
BIOTECHNOLOGY<br />
CLINICAL<br />
DIAGNOSTIC<br />
HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
PHARMACEUTICAL<br />
Global Leading Equipment and System Manufacturers<br />
Component Providers and System Integrators<br />
Distributors, Retailors and Value Added Resellers<br />
Healthcare IT Solutions Developers<br />
<strong>Market</strong>ing Consultancies and the Advertising Industry<br />
Private and Government organization<br />
Outsourcing Companies<br />
Universities and Business Schools.
ABOUT US<br />
KEY STATS<br />
100<br />
+<br />
150+<br />
Insights Published Per Year<br />
Consulting Projects Till<br />
Date<br />
125+<br />
Clients Worldwide Per Year<br />
110+<br />
Analysts and Contract<br />
Consultants<br />
RESEARCH<br />
SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEARCH<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
TECHNOLOGY<br />
SNIPPETS<br />
COUNTRY<br />
ANALYSIS<br />
COMPETITIVE<br />
ASSESSMENT<br />
Coherent <strong>Market</strong> Insights excels at offering unmatched actionable market intelligence across various industry verticals, including<br />
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
THANK YOU<br />
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> Insights<br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702
Change language